RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION

肾微血管内皮细胞分化

基本信息

  • 批准号:
    6301224
  • 负责人:
  • 金额:
    $ 18.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-12-15 至 2000-11-30
  • 项目状态:
    已结题

项目摘要

Description: (Abstract of the project) The development, maintenance and reestablishment of renal glomerular and tubular structure and function are areas of intense interest and investigation. Reversible renal glomerular and tubular dysfunctions are noted in a variety of disease states. Advances in our understanding of renal function in the last five years have mainly been in the areas of epithelial cell-cell, cell-matrix and cell-growth factor interactions and in the development of adherens and tight junctional complexes. While the development, maintenance and regulation of endothelial barrier function has been well-studied functionally, the relative flatness of the endothelial cell compared to most epithelial cells studied has resulted in slower progress in morphological-based investigations. Endothelial cell adherens junctions contain an endothelial specific cadherin - VE-cadherin which complexes to (alpha- and beta-catenin, plakoglobin and p120cas and recent studies have found that endothelial permeability is modulated by regulation of the adherens junctions. Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1 /CD31), an Ig family member expressed on endothelia from the hemangioblast stage through adulthood, is located at lateral borders of endothelial cells and is thought to play a role in the early stages of vascular genesis and angiogenesis. In this proposal we will examine the role of PECAM-1 as a beta-catenin binding moiety and as a scaffolding upon which beta-catenin phosphorylation is regulated, thus regulating beta-catenin's participation in adherens junction formation and gene expression. The hypothesis to be tested is that PECAM-1 is essential for the formation, maintenance and dynamic modulation of renal endothelial cell junctions. Signaling pathways involving dynamic selective PECAM-1 tyrosine and serine/threonine phosphorylation/ dephosphorylation in vascular endothelial cells will be elucidated using a variety of methods to determine the roles of PECAM-1 in the development and maintenance of endothelial differentiation and polarity and during responses to hypoxic injury.
产品描述:(项目摘要)肾小球和肾小管结构和功能的发育、维持和重建是人们强烈关注和研究的领域。可逆性肾小球和肾小管功能障碍在多种疾病状态下均可观察到。在过去的五年里,我们对肾功能的理解主要是在上皮细胞-细胞,细胞-基质和细胞-生长因子相互作用以及粘附和紧密连接复合物的发展方面。虽然内皮屏障功能的发展、维持和调节在功能上已经得到了很好的研究,但与大多数研究的上皮细胞相比,内皮细胞的相对平坦性导致了基于形态学的研究进展较慢。内皮细胞粘附连接包含内皮特异性钙粘蛋白-VE-钙粘蛋白,其与α-和β-连环蛋白、斑珠蛋白和p120 cas复合,并且最近的研究发现内皮渗透性通过调节粘附连接来调节。血小板内皮细胞粘附分子-1(PECAM-1 /CD 31)是IG家族成员,从成血管细胞阶段到成年期在内皮细胞上表达,位于内皮细胞的侧缘,被认为在血管发生和血管生成的早期阶段发挥作用。在这个提议中,我们将研究PECAM-1作为β-连环蛋白结合部分的作用,以及作为调节β-连环蛋白磷酸化的支架,从而调节β-连环蛋白参与粘附连接形成和基因表达。待检验的假设是PECAM-1对于肾内皮细胞连接的形成、维持和动态调节是必需的。将使用多种方法阐明涉及血管内皮细胞中动态选择性PECAM-1酪氨酸和丝氨酸/苏氨酸磷酸化/去磷酸化的信号通路,以确定PECAM-1在内皮分化和极性的发展和维持中以及在对缺氧损伤的反应期间的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH A MADRI其他文献

JOSEPH A MADRI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH A MADRI', 18)}}的其他基金

Endothelial-neuronal interactions during development
发育过程中内皮-神经元相互作用
  • 批准号:
    6740610
  • 财政年份:
    2003
  • 资助金额:
    $ 18.46万
  • 项目类别:
RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION
肾微血管内皮细胞分化
  • 批准号:
    6564382
  • 财政年份:
    2001
  • 资助金额:
    $ 18.46万
  • 项目类别:
RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION
肾微血管内皮细胞分化
  • 批准号:
    6410371
  • 财政年份:
    2000
  • 资助金额:
    $ 18.46万
  • 项目类别:
RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION
肾微血管内皮细胞分化
  • 批准号:
    6105917
  • 财政年份:
    1999
  • 资助金额:
    $ 18.46万
  • 项目类别:
RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION
肾微血管内皮细胞分化
  • 批准号:
    6105376
  • 财政年份:
    1998
  • 资助金额:
    $ 18.46万
  • 项目类别:
RENAL MICROVASCULAR ENDOTHELIAL CELL DIFFERENTIATION
肾微血管内皮细胞分化
  • 批准号:
    6238934
  • 财政年份:
    1997
  • 资助金额:
    $ 18.46万
  • 项目类别:
PROTEINASE MODULATION DURING T CELL-ENDOTHELIAL ADHESION
T 细胞内皮粘附过程中的蛋白酶调节
  • 批准号:
    2460025
  • 财政年份:
    1995
  • 资助金额:
    $ 18.46万
  • 项目类别:
Proteinase Modulation During T-Cell-Endothelial Adhesion
T 细胞内皮粘附过程中的蛋白酶调节
  • 批准号:
    6731165
  • 财政年份:
    1995
  • 资助金额:
    $ 18.46万
  • 项目类别:
Proteinase Modulation Diring T-Cell Endothelial Adhesion
蛋白酶调节指导 T 细胞内皮粘附
  • 批准号:
    7754045
  • 财政年份:
    1995
  • 资助金额:
    $ 18.46万
  • 项目类别:
PROTEINASE MODULATION DURING T CELL-ENDOTHELIAL ADHESION
T 细胞内皮粘附过程中的蛋白酶调节
  • 批准号:
    2227386
  • 财政年份:
    1995
  • 资助金额:
    $ 18.46万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了